Literature DB >> 19094851

Oculocutaneous albinism type 1A: a case report.

Ali Karaman1.   

Abstract

The term, oculocutaneous albinism (OCA), describes a group of inherited disorders of melanin biosynthesis that exhibits congenital hypopigmentation of ocular and cutaneous tissues. The clinical spectrum of OCA ranges from a complete lack of melanin pigmentation to mildly hypopigmented forms. OCA1A is the most severe type with a complete lack of melanin production throughout life; the milder forms OCA1B, OCA2, OCA3 and OCA4 show some pigment accumulation over time. Clinical manifestations include various degrees of congenital nystagmus, iris hypopigmentation and translucency, reduced pigmentation of the retinal pigment epithelium, foveal hypoplasia, reduced visual acuity and refractive errors, color vision impairment, and prominent photophobia. All four types of OCA are inherited as autosomal recessive disorders. At least four genes are responsible for the different types of the disease (TYR, OCA2, TYRP1, and MATP). Diagnosis is based on clinical findings of hypopigmentation of the skin and hair in addition to the characteristic ocular symptoms. Herein we present a case with OCA1A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19094851

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  4 in total

1.  Ocular findings in patients with oculocutaneous albinism type ia with G47D tyrosinase gene mutation in Puerto Rico: a case report.

Authors:  Ferdinand Rodríguez-Agramonte; Natalio J Izquierdo; Carmen Cadilla
Journal:  Bol Asoc Med P R       Date:  2013

2.  In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium.

Authors:  Aman George; Ruchi Sharma; Tyler Pfister; Mones Abu-Asab; Nathan Hotaling; Devika Bose; Charles DeYoung; Justin Chang; David R Adams; Tiziana Cogliati; Kapil Bharti; Brian P Brooks
Journal:  Stem Cell Reports       Date:  2022-01-11       Impact factor: 7.765

3.  Genetic Analysis of Oculocutaneous Albinism Type1A (OCA1A) in an Iranian Family.

Authors:  H Pour-Jafari; A Zamanian; B Pour-Jafari
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

4.  Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).

Authors:  Vadieh Ghodsinejad Kalahroudi; Behnam Kamalidehghan; Ahoura Arasteh Kani; Omid Aryani; Mahdi Tondar; Fatemeh Ahmadipour; Lip Yong Chung; Massoud Houshmand
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.